What are the recommended drug regimens for treating enteric (typhoid) fever in an otherwise healthy adult?

Recommended Drug Regimens for Enteric Fever in Healthy Adults

For uncomplicated enteric fever in healthy adults, azithromycin is the preferred first-line treatment, with ceftriaxone as the second-line option, though local resistance patterns must guide final selection. 1

First-Line Treatment Options

Azithromycin (Preferred)

• Dosing: 500 mg orally once daily for 7 days 2
• Rationale: Azithromycin demonstrates superior outcomes compared to fluoroquinolones, with lower clinical failure rates (OR 0.48,95% CI 0.26-0.89) and shorter hospital stays (-1.04 days) 1. It also shows lower relapse rates compared to ceftriaxone (OR 0.09,95% CI 0.01-0.70) 1.
• Clinical efficacy: Achieves 88% cure/improvement by day 8 and 100% by day 14, with 100% bacterial eradication by day 8 2

Fluoroquinolones (Geographic Limitations)

• Ciprofloxacin or ofloxacin are WHO-recommended first-line agents 1
• Critical caveat: Fluoroquinolones should NOT be used for infections originating from South Asia due to widespread resistance 3
• This is a major pitfall—always determine travel history before prescribing fluoroquinolones

Second-Line Treatment Options

Ceftriaxone

• Indication: When azithromycin fails or in quinolone-resistant cases 1
• Evidence: May result in decreased clinical failure compared to azithromycin (RR 0.42,95% CI 0.11-1.57), though evidence certainty is low 4
• Advantage: Effective against most resistant strains, including many fluoroquinolone-resistant isolates

Cefixime (Oral Alternative)

• Caution: May have increased clinical failure (RR 13.39,95% CI 3.24-55.39), microbiological failure, and relapse compared to fluoroquinolones 4
• Consider only when other options are unavailable

Critical Resistance Considerations

Extensively Drug-Resistant (XDR) Typhoid

• Geographic concern: Ongoing outbreak in Pakistan since 2016 5
• Treatment: Requires azithromycin and/or meropenem 6
• XDR strains are resistant to chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole, ciprofloxacin, and ceftriaxone 6

Regional Resistance Patterns

• South Asia: Ciprofloxacin resistance is common; avoid fluoroquinolones 3
• Pakistan: Both ciprofloxacin-resistant and ceftriaxone-resistant typhoid are prevalent 3
• Some regions show re-emergence of susceptibility to older agents like chloramphenicol 6

Treatment Algorithm

1. Obtain travel history immediately to assess resistance risk
2. If South Asian origin: Start azithromycin (avoid fluoroquinolones)
3. If non-South Asian origin with known susceptibility: Fluoroquinolones acceptable
4. If suspected XDR or treatment failure: Switch to azithromycin + meropenem
5. Always obtain blood cultures before starting treatment to guide therapy

Common Pitfalls to Avoid

• Do not use fluoroquinolones empirically without knowing geographic origin—this is the most critical error given widespread South Asian resistance 3
• Do not assume older first-line agents are obsolete—resistance patterns are dynamic and chloramphenicol susceptibility has re-emerged in some areas 6
• Do not use cefixime as first-line given inferior outcomes compared to other options 4
• Do not forget to check for XDR strains in Pakistani travelers, as standard regimens will fail 5, 6

Duration and Monitoring

• Azithromycin: 7 days is sufficient 2
• Chloramphenicol (if used): 14 days required 2
• Expected response: Fever should resolve within 3-7 days; lack of improvement by day 8 suggests resistance or treatment failure 4

The evidence strongly supports azithromycin as the optimal empiric choice for most cases, with the critical exception being that geographic origin and local resistance patterns must override general recommendations 1, 3, 6.